Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

Nationwide Recall of Stamina-Rx Dietary Supplement
Hi-Tech Pharmaceuticals, Inc. is conducting a nationwide recall of all lots of their product Stamina-Rx. This product is being recalled because it may contain an undeclared ingredient called benzamidenafil. Benzamidenafil is in the same class of medicines that include the Phosphodiesterase Type 5 (PDE5) inhibitors sildenafil, tadalafil, and vardenafil, that are FDA-approved for the treatment of erectile dysfunction (ED). Benzamidenafil is not FDA-approved, and poses a threat to consumers because benzamidenafil may interact with nitrates found in some prescription drugs (such as nitroglycerin) and lower blood pressure to dangerous levels. Stamina-Rx is sold in health food and drug stores nationwide. The product is sold in 10, 30, and 40-tablet bottles and in 2 and 6-tablet blister packs. All Stamina-Rx products are being recalled by the manufacturer. For more information, please visit: http://www.fda.gov/Safety/Recalls/ucm167139.htm
Learn More

Recall of Single Lot of Equate Ibuprofen Tablets, 200 mg
L. Perrigo Co has voluntarily recalled a single lot of Equate Ibuprofen 200 mg tablets packaged in bottles of 100 tablets. The bottles were available for over-the-counter purchase in Arkansas. These recalled tablets have a lot number 9BE1961. These tablets are being recalled because there may be metal shavings in the containers. For more information, please visit: http://www.fda.gov/Safety/Recalls/EnforcementReports/ucm164181.htm
Learn More

Receive Safety Alerts & Recalls by email or text message.

Register

Date Published Title Drug Source
2009-06-18 Nationwide Recall of Stamina-Rx Dietary Supplement FDA
2009-06-17 Recall of Single Lot of Equate Ibuprofen Tablets, 200 mg Ibuprofen FDA
2009-06-17 Recall of Single Lot of Furosemide Tablets, 40 mg Furosemide FDA
2009-06-17 FDA Update on Ongoing Safety Review of Cefepime (Maxipime) Cefepime FDA
2009-06-16 Ongoing FDA Safety Review of Stimulant Mediations Used to Treat ADHD in Children FDA
2009-06-16 Ongoing FDA Safety Review of Stimulant Mediations Used to Treat ADHD in Children Methylphenidate FDA
2009-06-16 Ongoing FDA Safety Review of Stimulant Mediations Used to Treat ADHD in Children Amphetamine Salts FDA
2009-06-16 Ongoing FDA Safety Review of Stimulant Mediations Used to Treat ADHD in Children Cylert FDA
2009-06-16 Warnings on Three Zicam Intranasal Zinc Products Zicam FDA
2009-06-16 Warnings on Three Zicam Intranasal Zinc Products Zinc FDA
2009-06-15 Select Lots of Levemir Insulin (Insulin Detemir [rDNA origin] Injection) Reported Stolen Insulin Detemir FDA
2009-06-15 Ongoing FDA Safety Review of Stimulant Mediations Used to Treat ADHD in Children Dexmethylphenidate FDA
2009-06-15 Ongoing FDA Safety Review of Stimulant Mediations Used to Treat ADHD in Children Dextroamphetamine FDA
2009-06-15 Ongoing FDA Safety Review of Stimulant Mediations Used to Treat ADHD in Children Lisdexamfetamine FDA
2009-06-12 Updated Safety Information from FDA Safety Review Montelukast FDA
2009-06-12 Updated Safety Information from FDA Safety Review Zafirlukast FDA
2009-06-12 Updated Safety Information from FDA Safety Review Zileuton FDA
2009-06-11 New Safety Information About the Use of Sirolimus (Rapamune) in LIVER Transplant Patients Sirolimus FDA
2009-06-08 Thiazolidinediones Associated with Increased Risk of Fractures Pioglitazone MediGuard CRT
2009-06-08 Thiazolidinediones Associated with Increased Risk of Fractures Rosiglitazone MediGuard CRT